Oscar Health Inc (OSCR)
21.64
0.00 (0.00%)
USD |
NYSE |
May 13, 11:29
Oscar Health SG&A Expense (Quarterly): 394.70M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 394.70M |
December 31, 2023 | 85.61M |
September 30, 2023 | 75.50M |
June 30, 2023 | 76.45M |
March 31, 2023 | 396.98M |
December 31, 2022 | 75.81M |
September 30, 2022 | 78.56M |
June 30, 2022 | 80.75M |
March 31, 2022 | 74.66M |
Date | Value |
---|---|
December 31, 2021 | 89.34M |
September 30, 2021 | 60.00M |
June 30, 2021 | 51.17M |
March 31, 2021 | 64.57M |
December 31, 2020 | 62.28M |
September 30, 2020 | 36.55M |
June 30, 2020 | 35.99M |
March 31, 2020 | 31.84M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
31.84M
Minimum
Mar 2020
396.98M
Maximum
Mar 2023
104.16M
Average
75.50M
Median
Sep 2023
SG&A Expense (Quarterly) Benchmarks
Clover Health Investments Corp | 103.79M |
Alignment Healthcare Inc | 90.51M |
NeueHealth Inc | 56.51M |
The Cigna Group | 3.705B |
UnitedHealth Group Inc | -- |